Exceeds Expectations Delivers Double Digit Revenue Growth MALVERN, Pa., Nov. 05, 2019 (GLOBE NEWSWIRE) — BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, today reported results for the third quarter ended September […]
Financial
Avinger Reports Third Quarter 2019 Financial Results
Increased Utilization Drives 33% Growth in Catheter Sales and Gross Margin Expansion Total Pantheris Revenue Increases 81% Year-over-Year REDWOOD CITY, Calif., Nov. 05, 2019 (GLOBE NEWSWIRE) — Avinger, Inc. (Nasdaq: AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of […]
Sasha Gentling, CFA Joins BioSig as Director of Business Development
Former Investment Officer at Mayo Clinic to oversee relationships in the Midwest Westport, CT, Nov. 06, 2019 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or “The Company”), a medical technology company developing a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the full range […]
iRhythm Technologies Announces Third Quarter 2019 Financial Results
SAN FRANCISCO, Nov. 05, 2019 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today reported financial results for the three months ending September 30, 2019. Third Quarter 2019 and Recent Highlights Revenue of $56.0 million for the […]
CHF Solutions, Inc. Announces Third Quarter Financial Results and Provides Company Update
EDEN PRAIRIE, Minn., Nov. 05, 2019 (GLOBE NEWSWIRE) — CHF Solutions, Inc. (Nasdaq: CHFS), a medical device company focused on developing, manufacturing and commercializing a clinically proven solution for diuretic-resistant patients suffering from fluid overload, announced today its results for the third quarter ended September 30, 2019, which included the […]
MyoKardia Reports Third Quarter 2019 Financial Results
SOUTH SAN FRANCISCO, Calif., Nov. 04, 2019 (GLOBE NEWSWIRE) — MyoKardia, Inc. (Nasdaq: MYOK), today reported financial results for the quarter ended September 30, 2019. “As we look across the milestones recently achieved and those just ahead, we see steady progress on our near- and long-term corporate objectives. We are […]
Amarin Reports Third Quarter 2019 Financial Results and Provides Update on Operations
Record Revenue Levels and Preparations On-Track for Further Expansion Management to Host Conference Call at 7:30 a.m. ET Today DUBLIN, Ireland and BRIDGEWATER, N.J., Nov. 05, 2019 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ:AMRN), a pharmaceutical company focused on improving cardiovascular health, today announced financial results for the three and nine […]
Cook Medical India Opens New Facility in Chennai
CHENNAI, India–(BUSINESS WIRE)–Cook Medical India celebrated its new office opening. The company has shifted to a modern, 20,000-square foot office at Kochar Jade in Guindy, Chennai. It is located at the city’s major business district with easy access to land and air freight stations. India is an important part of […]
Ra Medical Systems Announces Substantial Completion of Audit Committee Investigation
CARLSBAD, Calif.–(BUSINESS WIRE)–Ra Medical Systems, Inc. (NYSE: RMED), a medical device company focusing on commercializing excimer laser systems to treat vascular and dermatological diseases, today announced that the Audit Committee of the Board of Directors (the “Audit Committee”) has substantially completed its internal investigation, which was originally announced in August. […]
SignPath Pharma, Inc. Announces an Out-license Agreement of Its CorreQTTM Technology for Mitigation of QT Prolongation with Rain Therapeutics Inc.
SALT LAKE CITY–(BUSINESS WIRE)–SignPath Pharma (Salt Lake City UT) today announced the first commercial out-license of its proprietary CorreQT technology platform. SignPath entered into an agreement with Rain Therapeutics (Newark CA), which licenses SignPath’s CorreQT technology for use in conjunction with Rain’s proprietary lead compound, Tarlox® (tarloxotinib,) a potent pan-ErbB […]



